在孕妇AV阻塞患者中NKX2-5突变和ICD植入
Musa'ab Moh'd Alhmouz1, Alaa Jamal Saeid1, Mohamed A L Jaabari1
1Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
JACC. Case reports
|November 7, 2025
概括
一名患有NKX2-5基因突变的孕妇经历了渐进性心脏阻塞. 她成功地接收了可植入的心脏转换器-除器,使得怀孕和分娩没有任何并发症.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 孕产妇和胎儿医学 孕产妇和胎儿医学
背景情况:
- 怀孕涉及生理变化,可以加剧心律失常和导电障碍.
- 新发作的完全心脏阻塞,虽然很少见,与NKX2-5基因突变,先天性心脏疾病和渐进的导电缺陷有关.
研究的目的:
- 报告一个怀孕妇女患有NKX2-5基因突变的病例,呈现出进展性心房节点疾病和慢性无能.
- 在这种情况下,强调在怀孕期间装置植入的管理和结果.
主要方法:
- 一个已知NKX2-5基因突变的孕妇的病例介绍.
- 描述渐进的心节点疾病和慢性无能.
- 在怀孕期间安装双室植入式心脏转换器-除器 (ICD) 的细节.
主要成果:
- 该患者成功地进行了双室ICD植入.
- 这项手术耐受性很好.
- 怀孕和分娩没有任何并发症.
结论:
- 设备植入在怀孕期间是可行的,用于管理复杂的心脏病状况.
- 遗传洞察力和多学科护理对于在怀孕期间管理NKX2-5相关的心脏问题至关重要.
- 需要进一步的研究和共同的临床经验,以制定在怀孕期间管理导电突变的指导方针.
相关概念视频
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
2.7K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.7K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
445
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
445
Cardiomyopathy V: Interprofessional Care
323
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
323
Mitral Valve Prolapse III: Nursing Management
273
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
273
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.8K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.8K


